Skip to main content
Cancers logoLink to Cancers
. 2020 Oct 1;12(10):2846. doi: 10.3390/cancers12102846

Correction: Liu, H.W.; et al. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma. Cancers 2019, 11, 1888

Heng-Wei Liu 1,2,3,4, Peter Mingjui Lee 5, Oluwaseun Adebayo Bamodu 4,6,7, Yu-Kai Su 1,2,3,4, Iat-Hang Fong 3,4, Chi-Tai Yeh 1,4,6,7,8, Ming-Hsien Chien 1, I-Hung Kan 1,2,3,4,*, Chien-Min Lin 1,2,3,4,*
PMCID: PMC7600312  PMID: 33019761

The authors wish to make the following corrections to this paper [1]:

After the publication of this work, we were notified of the mistakes in Figure 2E and Section 3.2, which have now been updated in this correction.

Figure 2.

Figure 2

(E) Flow-cytometry data (upper) and graphical representation (lower) showing the effect of Garcinol, alone or in presence of Z-VAD-FMK, on U87MG or GBM8401 cells co-stained with PE-conjugated Annexin V and 7-AAD, compared with untreated control or Z-VAD-FMK-treated negative control groups. Annexin V-stained Q4 cells are early apoptotic cells, whereas Q2 cells are late apoptotic (necrotic) cells. Apoptosis (%), sum of Q4 + Q2; CTL, vehicle-treated; Neg CTL, pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-VAD-FMK).

The original Figure 2E and legend of Figure 2E are as below:

and should be replaced with the following:

In addition, the authors reported errors in Section 3.2 when analyzing the original data in Figure 2E. Thus, the authors wish to replace the following sentence in Section 3.2:

Figure 2.

Figure 2

(E) Flow-cytometry data (upper) and graphical representation (lower) showing the effect of garcinol, alone or in presence of Z-VAD-FMK, on U87MG or GBM8401 cells co-stained with PE-conjugated annexin V and 7-AAD, compared with untreated control or Z-VAD-FMK-treated negative control groups. Annexin V-stained Q3 cells are early apoptotic cells, whereas Q2 cells are late apoptotic (necrotic) cells. Apoptosis (%), sum of Q3 + Q2; CTL, vehicle-treated; Neg CTL, pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-VAD-FMK).

“…and 7.97% or 14.11% apoptosis of the U87MG cells (Figure 2E), indicating that the garcinol-induced cell death was apoptotic and caspase-dependent.”

with:

“…and 7.97% or 12.99% apoptosis of the U87MG cells (Figure 2E), indicating that the garcinol-induced cell death was apoptotic and caspase-dependent.”

The corrections made in this erratum do not affect the original conclusions. The authors would like to apologize for any inconvenience caused to the readers by these changes.

References

  • 1.Liu H.-W., Lee P.M., Bamodu O.A., Su Y.-K., Fong I.-H., Yeh C.-T., Chien M.-H., Kan I.-H., Lin C.-M. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma. Cancers. 2019;11:1888. doi: 10.3390/cancers11121888. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES